NLM Digital Collections

Search

Start Over Authors Whittington, Melanie D., author ✖Remove constraint Authors: Whittington, Melanie D., author Publication Year 2023 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2023">2023</span>

1. Lecanemab for early Alzheimer’s disease: final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Agboola, Foluso, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David, (Of Institute for Clinical and Economic Review), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 17, 2023
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal, Humanized
United States

2. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D, author
Campbell, Jonathan D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States